Mauritius - BiotechnologyMauritius-Biotechnology
This is a best prospect industry sector for this country.
Overview
The biotech industry in Mauritius is young but growing. Since 2014, five companies have operated at a dedicated BioPark with modern infrastructure for biotechnology research and development. Governmental organizations such as the Mauritius Research Council, the Center for Biomedical & Biomaterials Research, and the Food and Agricultural Research & Extension Institute support the budding biotechnology industry through their research. There are currently 20 companies employing about 800 people in the biotech sector (excluding medical devices and manufacturing of pharmaceuticals). These companies are involved in different types of activities such as clinical trials, breeding of primates for export, production of fish oil and manufacture of biofuels. The table below, updated as of 2018, provides further details on the industry in Mauritius:
Sub-Sector |
Number of Companies |
Company |
Red Biotechnology (Medical) | ||
Contract Research Organizations (Clinical Trials) |
4 |
|
Breeding for Contract Research |
4 |
|
Analytical Laboratories/Research Laboratories |
4 |
|
Blue Biotechnology (Marine) | ||
Fish oil extraction & production and extraction of molecules from by-products for different applications |
3 |
|
Grey Biotechnology | ||
Production of landfill gas for energy generation and conversion of organic waste into compost |
2 |
|
White Biotechnology (Industrial) | ||
Production of ethanol |
1 |
|
Leading Sub-Sectors
Leading sub-sectors include:
-
Pre-clinical and clinical trials
-
Breeding for pre-clinical trials
-
Stem cell therapy
-
Phytotherapy research and development
-
Agro-industry applications
-
Marine biotechnolgy
Opportunities
The government has indicated a commitment to develop the biotech industry. The GOM announced in 2016 that Mauritius will adhere to the Patent Cooperation Treaty, the Hague Convention, and the Madrid Protocol to facilitate registration of patents, trademarks, and industrial designs. The Industrial Property Bill, which provides for Mauritius’ accession to the Madrid Protocol, was introduced in parliament in July 2019. In the 2019–2020 budget speech, the government announced the following measures to promote biotechnology: (i) introduction of a regulatory framework for the classification and registration of nutraceuticals; (ii) amendments to the Clinical Trials Act to provide for registration of Contract Research Organisations with the Clinical Research Regulatory Council and to allow for trials involving medical devices; and (iii) development of a regulatory framework aligned with EU and U.S. standards for stem cell research and therapy.
There are opportunities for:
-
U.S. companies to export lab supplies and biotechnology equipment
-
Setting up pre-clinical and clinical trial labs
-
Research and development in plant-based and marine-based pharmaceuticals
-
Research and development for agro-industry applications
Web Resources
Economic Development Board: https://www.edbmauritius.org/
Biotechnology Cluster Staff, Economic Development Board, 10th Floor, One Cathedral Square Building, 16, Jules Koenig Street, Port Louis 11328, Tel: + 230 203 3800, Fax: +230 210 8560